Yueting Chen

408 total citations
17 papers, 306 citations indexed

About

Yueting Chen is a scholar working on Pharmacology, Infectious Diseases and Molecular Biology. According to data from OpenAlex, Yueting Chen has authored 17 papers receiving a total of 306 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pharmacology, 3 papers in Infectious Diseases and 3 papers in Molecular Biology. Recurrent topics in Yueting Chen's work include Antibiotics Pharmacokinetics and Efficacy (5 papers), Epilepsy research and treatment (3 papers) and Antimicrobial Resistance in Staphylococcus (2 papers). Yueting Chen is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (5 papers), Epilepsy research and treatment (3 papers) and Antimicrobial Resistance in Staphylococcus (2 papers). Yueting Chen collaborates with scholars based in China, Portugal and Pakistan. Yueting Chen's co-authors include Ying Shao, Fang Liu, Xin Sheng, Guoyuan Lu, Jingjing Zhang, Xiaomin Lu, Qiang Xu, Zheng Jiao, Chenyu Wang and Cynthia F. Bartels and has published in prestigious journals such as Neurology, Nature Methods and Chemistry - A European Journal.

In The Last Decade

Yueting Chen

15 papers receiving 302 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yueting Chen China 8 160 95 63 27 23 17 306
Ruijuan Luo United States 10 194 1.2× 90 0.9× 95 1.5× 16 0.6× 9 0.4× 15 431
Sridhar Veeraraghavan India 11 127 0.8× 40 0.4× 84 1.3× 26 1.0× 39 1.7× 27 345
Hiroko Kokuba Japan 13 191 1.2× 63 0.7× 32 0.5× 16 0.6× 12 0.5× 19 414
Bijan Almassian United States 11 121 0.8× 120 1.3× 76 1.2× 17 0.6× 21 0.9× 25 332
Mary Zoeckler United States 11 180 1.1× 203 2.1× 72 1.1× 27 1.0× 18 0.8× 14 485
Lisa Urquhart 11 261 1.6× 48 0.5× 55 0.9× 16 0.6× 13 0.6× 27 470
Huaxiang Tong United States 13 296 1.9× 88 0.9× 52 0.8× 21 0.8× 61 2.7× 16 389
Dóra Türk Hungary 9 145 0.9× 226 2.4× 52 0.8× 14 0.5× 34 1.5× 11 327
Zhangxu He China 12 273 1.7× 112 1.2× 192 3.0× 19 0.7× 13 0.6× 28 491
Vyacheslav G. Tribulovich Russia 12 242 1.5× 178 1.9× 101 1.6× 13 0.5× 26 1.1× 37 426

Countries citing papers authored by Yueting Chen

Since Specialization
Citations

This map shows the geographic impact of Yueting Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yueting Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yueting Chen more than expected).

Fields of papers citing papers by Yueting Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yueting Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yueting Chen. The network helps show where Yueting Chen may publish in the future.

Co-authorship network of co-authors of Yueting Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Yueting Chen. A scholar is included among the top collaborators of Yueting Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yueting Chen. Yueting Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Yang, Yang, Chenyu Wang, Yueting Chen, et al.. (2024). Trilaciclib dosage in Chinese patients with extensive-stage small cell lung cancer: a pooled pharmacometrics analysis. Acta Pharmacologica Sinica. 45(10). 2212–2225.
2.
Chen, Yueting, Cansheng Gong, Feng Liu, Zheng Jiao, & Xiaochun Zheng. (2024). Toward Model-Informed Precision Dosing for Remimazolam: A Population Pharmacokinetic–Pharmacodynamic Analysis. Pharmaceutics. 16(9). 1122–1122.
3.
Jiao, Zheng, Yun Shen, Zhe Chen, et al.. (2023). External evaluation of the predictive performance of published population pharmacokinetic models of linezolid in adult patients. Journal of Global Antimicrobial Resistance. 35. 347–353. 1 indexed citations
4.
Liu, Xiaoqin, Ziran Li, Chenyu Wang, Yueting Chen, & Zheng Jiao. (2023). Is a Lower Dose of Rivaroxaban Required for Asians? A Systematic Review of a Population Pharmacokinetics and Pharmacodynamics Analysis of Rivaroxaban. Pharmaceutics. 15(2). 588–588. 11 indexed citations
5.
Cai, Xinjun, et al.. (2023). Parametric population pharmacokinetics of isoniazid: a systematic review. Expert Review of Clinical Pharmacology. 16(5). 467–489. 6 indexed citations
6.
Chen, Yueting, Yang Yang, Chenyu Wang, et al.. (2023). Model Informed Development of SIM0295 in Patients with Gout and Hyperuricemia and Healthy Volunteers Using a Population Pharmacokinetics/ Pharmacodynamics Approach. Expert Opinion on Investigational Drugs. 32(5). 441–450. 1 indexed citations
7.
Wang, Chenyu, et al.. (2023). External evaluation and systematic review of population pharmacokinetic models for high-dose methotrexate in cancer patients. European Journal of Pharmaceutical Sciences. 186. 106416–106416. 7 indexed citations
8.
Zhang, Lili, et al.. (2022). Parametric population pharmacokinetics of linezolid: A systematic review. British Journal of Clinical Pharmacology. 88(9). 4043–4066. 15 indexed citations
9.
Li, Ziran, et al.. (2022). Handling Delayed or Missed Dose of Antiseizure Medications. Neurology. 100(9). e921–e931. 9 indexed citations
10.
Chen, Yueting, Muhammad Abbas, Hajra Zafar, et al.. (2022). Understanding of Immune Escape Mechanisms and Advances in Cancer Immunotherapy. Journal of Oncology. 2022. 1–13. 31 indexed citations
11.
Shan, Xiaoxiao, Ling Li, Yueting Chen, et al.. (2022). Phytochemical profile and protective effects on myocardial ischaemia-reperfusion injury of sweated and non-sweated Salvia miltiorrhiza. Bge alcoholic extracts. Journal of Pharmacy and Pharmacology. 74(9). 1230–1240. 3 indexed citations
12.
Chen, Yueting, et al.. (2021). Population pharmacokinetics of oxcarbazepine: a systematic review. Expert Review of Clinical Pharmacology. 14(7). 853–864. 17 indexed citations
13.
Wazir, Junaid, et al.. (2020). Experimental autoimmune prostatitis: different antigens induction and antigen-specific therapy. International Urology and Nephrology. 53(4). 607–618. 14 indexed citations
14.
Wang, Jintao, et al.. (2019). Discovery of aryl sulfonamide-selective Nav1.7 inhibitors with a highly hydrophobic ethanoanthracene core. Acta Pharmacologica Sinica. 41(3). 293–302. 5 indexed citations
15.
Shen, Pan‐Pan, et al.. (2017). [Effect of Acupuncture at "Taichong"(LR 3) and "Neiguan"(PC 6) on Blood Pressure and Contents of Aspartic Acid and Glutamic Acid in the Rostral Ventrolateral Medulla in Spontaneous Hypertension Rats].. PubMed. 42(2). 102–6. 3 indexed citations
16.
Zhang, Xiaodong, Chunguang Guo, Yueting Chen, et al.. (2008). Epitope tagging of endogenous proteins for genome-wide ChIP-chip studies. Nature Methods. 5(2). 163–165. 80 indexed citations
17.
Sheng, Xin, Xiaomin Lu, Yueting Chen, et al.. (2007). Synthesis, DNA‐Binding, Cleavage, and Cytotoxic Activity of New 1,7‐Dioxa‐4,10‐diazacyclododecane Artificial Receptors Containing Bisguanidinoethyl or Diaminoethyl Double Side Arms. Chemistry - A European Journal. 13(34). 9703–9712. 103 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026